FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products

    NEXT STORY
    Mateon Therapeutics Team Publishes Three New Peer-Reviewed Oncology Articles Outlining the Clinical Impact Potential of Its First-In-Class Anti-TGF-Beta RNA Therapeutic OT101/Trabedersen
    PREV STORY
    Fortress Biotech to Participate in December 2019 Investor Conferences
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    True Nature Holding Expands on “Digital Transformation in Healthcare” Strategy

    ATLANTA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- True Nature Holding, Inc. (OTCQB:TNTY) (the "Company" ...

    author_avatar
    NASDAQ Market News

    Global Ultraviolet Germicidal Irradiation (UVGI) Market to Reach $682.9 Million by 2026

    author_avatar
    NASDAQ Market News

    Insmed to Host Analyst and Investor Day on July 19, 2017

    BRIDGEWATER, N.J., July 12, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical ...

    author_avatar
    NASDAQ Market News